A Safety and Tolerability Study of ABT-089 in Children With Attention-Deficit/Hyperactivity Disorder (ADHD) - Contacts and Locations

Please refer to this study by its ClinicalTrials.gov identifier: NCT00554385

Locations


United States, Arkansas

	Little Rock, Arkansas, United States, 72205

United States, California

	El Centro, California, United States, 92243

United States, Colorado

	Boulder, Colorado, United States, 80304

United States, Florida

	Orlando, Florida, United States, 32806

	Jacksonville, Florida, United States, 32216

	Bradenton, Florida, United States, 34208

United States, Illinois

	Northbrook, Illinois, United States, 60062

	Libertyville, Illinois, United States, 60048

United States, Kansas

	Overland Park, Kansas, United States, 66212

United States, Michigan

	Troy, Michigan, United States, 48085

United States, Nebraska

	Omaha, Nebraska, United States, 68105

United States, Nevada

	Las Vegas, Nevada, United States, 89128

United States, New Jersey

	Clementon, New Jersey, United States, 08021

United States, Oklahoma

	Oklahoma City, Oklahoma, United States, 73103

United States, Oregon

	Salem, Oregon, United States, 97301

	Eugene, Oregon, United States, 97401

	Portland, Oregon, United States, 97210

United States, South Carolina

	Charleston, South Carolina, United States, 29405

United States, Tennessee

	Memphis, Tennessee, United States, 38119

United States, Texas

	Austin, Texas, United States, 78756

United States, Virginia

	Herndon, Virginia, United States, 20170

United States, Washington

	Bellevue, Washington, United States, 98004

United States, Wisconsin

	Middleton, Wisconsin, United States, 53562

Sponsors and Collaborators

Abbott

Investigators


Study Director:	Laura Gault, M.D., Ph.D.	Abbott